Hannah Galvin, MD, chief medical information officer at Cambridge Health Alliance, discusses implementing patient privacy, interoperability and health equity by balancing granular data segmentation and patient-driven consent-management tools.  

On the heels of a strong financial quarter in Q2, UnitedHealthcare has said it will eliminate out-of-pocket costs for insulin and other medications for eligible members, offering a zero cost share for five drugs in its fully insured group plans. Pending regulatory approval, this could take effect as soon as January 1, 2023.